1. Home
  2. AUPH vs PDX Comparison

AUPH vs PDX Comparison

Compare AUPH & PDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AUPH
  • PDX
  • Stock Information
  • Founded
  • AUPH 1993
  • PDX 2019
  • Country
  • AUPH Canada
  • PDX NY
  • Employees
  • AUPH N/A
  • PDX N/A
  • Industry
  • AUPH Biotechnology: Pharmaceutical Preparations
  • PDX Finance/Investors Services
  • Sector
  • AUPH Health Care
  • PDX Finance
  • Exchange
  • AUPH Nasdaq
  • PDX Nasdaq
  • Market Cap
  • AUPH 1.1B
  • PDX 1.2B
  • IPO Year
  • AUPH 1999
  • PDX N/A
  • Fundamental
  • Price
  • AUPH $8.01
  • PDX $26.39
  • Analyst Decision
  • AUPH Strong Buy
  • PDX
  • Analyst Count
  • AUPH 3
  • PDX 0
  • Target Price
  • AUPH $10.33
  • PDX N/A
  • AVG Volume (30 Days)
  • AUPH 1.3M
  • PDX N/A
  • Earning Date
  • AUPH 02-13-2025
  • PDX 01-01-0001
  • Dividend Yield
  • AUPH N/A
  • PDX 4.95%
  • EPS Growth
  • AUPH N/A
  • PDX N/A
  • EPS
  • AUPH N/A
  • PDX N/A
  • Revenue
  • AUPH $220,361,000.00
  • PDX N/A
  • Revenue This Year
  • AUPH $36.97
  • PDX N/A
  • Revenue Next Year
  • AUPH $16.43
  • PDX N/A
  • P/E Ratio
  • AUPH N/A
  • PDX N/A
  • Revenue Growth
  • AUPH 38.72
  • PDX N/A
  • 52 Week Low
  • AUPH $4.71
  • PDX $13.52
  • 52 Week High
  • AUPH $10.67
  • PDX $21.05
  • Technical
  • Relative Strength Index (RSI)
  • AUPH 45.28
  • PDX 46.82
  • Support Level
  • AUPH $7.67
  • PDX $24.65
  • Resistance Level
  • AUPH $8.54
  • PDX $26.72
  • Average True Range (ATR)
  • AUPH 0.27
  • PDX 1.19
  • MACD
  • AUPH 0.03
  • PDX -0.42
  • Stochastic Oscillator
  • AUPH 43.62
  • PDX 22.35

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing LUPKYNIS (voclosporin), an investigational drug, for the treatment of lupus nephritis (LN), and others. Geographically, it derives maximum revenue from the United States.

About PDX PIMCO Dynamic Income Strategy Fund of Beneficial Interest

PIMCO Dynamic Income Strategy Fund is a non-diversified, limited term, closed-end management investment company registered under the Investment Company. The fund's primary investment objective is to seek current income as a primary objective and capital appreciation as a secondary objective.

Share on Social Networks: